pcDNA3-FLAG-MTOR-T1977R Citations (1)
Originally described in: A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM Cancer Discov. 2014 May;4(5):554-63. doi: 10.1158/2159-8290.CD-13-0929. Epub 2014 Mar 14. PubMed Journal
Articles Citing pcDNA3-FLAG-MTOR-T1977R
| Articles |
|---|
| Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFR(T790M)-Mutant NSCLC. Park HR, Kim TM, Lee Y, Kim S, Park S, Ju YS, Kim M, Keam B, Jeon YK, Kim DW, Heo DS. J Thorac Oncol. 2021 Jul 6. pii: S1556-0864(21)02254-1. doi: 10.1016/j.jtho.2021.06.013. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.